Ian Somaiya is the new CFO of NewAmsterdam Pharma
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) has announced the appointment of Ian Somaiya as Chief Financial Officer. Mr. Somaiya is a healthcare executive with significant financial and operational expertise, including over twenty years of experience as a prominent biotechnology research analyst on Wall Street. Mr. Somaiya comes to NewAmsterdam Pharma...